Published in Clin Exp Immunol on December 01, 1988
Natural killer cells in infection and inflammation of the lung. Immunology (2009) 1.46
Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J Allergy Clin Immunol (2008) 1.10
NK cells in immunotolerant organs. Cell Mol Immunol (2013) 1.01
Immunosuppression by pulmonary surfactant: mechanisms of action. Thorax (1990) 0.81
Immunogenicity of surfactant. I. Human alveolar surfactant. Clin Exp Immunol (1991) 0.80
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes. PLoS One (2016) 0.75
Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids (1970) 11.81
Phospholipid methylation and biological signal transmission. Science (1980) 3.02
Human natural killer cells: biologic and pathologic aspects. Lab Invest (1984) 2.99
A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol (1977) 2.60
Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers. Am Rev Respir Dis (1978) 1.98
The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol (1984) 1.81
Physical and physiological properties of dry lung surfactant. Nature (1978) 1.53
Single plate separation of lung phospholipids including disaturated phosphatidylcholine. J Lipid Res (1983) 1.40
Human alveolar macrophage support of lymphocyte responses to mitogens and antigens. Analysis and comparison with autologous peripheral-blood-derived monocytes and macrophages. Am Rev Respir Dis (1983) 1.37
Mechanisms of the renal response to plasma volume expansion. Can J Biochem Physiol (1959) 1.29
Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol (1985) 1.28
Natural killer cells are present in the normal human lung but are functionally impotent. J Clin Invest (1984) 1.11
Immunosuppressive activity of canine pulmonary surface active material. J Immunol (1979) 1.10
Natural killer cell activity in cigarette smokers and asbestos workers. Am Rev Respir Dis (1985) 1.08
Identification of the immunosuppressive components of canine pulmonary surface active material. J Immunol (1980) 1.04
Natural killer cell function in human lung is compartmentalized. Am Rev Respir Dis (1987) 1.02
Peturbation of lymphocyte response to concanavalin A by exogenous cholesterol and lecithin. Eur J Immunol (1978) 1.01
Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis (1988) 0.99
Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes. Thorax (1988) 0.98
Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery. Eur J Respir Dis (1986) 0.96
Isolation and culture of human alveolar type II epithelial cells. Characterization of their phospholipid secretion. Am Rev Respir Dis (1984) 0.94
Natural cytotoxic activity in human lungs. Clin Exp Immunol (1982) 0.93
Characterization of bovine surfactant for infants with respiratory distress syndrome. Pediatrics (1986) 0.92
An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids. J Immunol (1985) 0.91
Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile. Clin Exp Immunol (1988) 0.88
Natural killer cells. Annu Rev Med (1986) 0.87
Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells. J Immunol (1985) 0.87
Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma. Am Rev Respir Dis (1987) 0.77
Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax (1980) 2.28
Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci (1993) 2.15
Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax (1980) 1.82
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J (2003) 1.81
Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis (1981) 1.76
Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J (1999) 1.74
Late embolization of prosthetic mitral valve occluder with survival following reoperation. Ann Thorac Surg (1975) 1.73
Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet (2005) 1.67
G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J (2000) 1.53
Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma. Clin Exp Immunol (1978) 1.50
Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med (1994) 1.45
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest (1995) 1.43
Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis (1984) 1.41
Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis. Crit Care Med (1999) 1.40
Multiple myeloma: causes and consequences of delay in diagnosis. QJM (2007) 1.35
Cross talk between physical activity and appetite control: does physical activity stimulate appetite? Proc Nutr Soc (2003) 1.34
Interstitial lung disease and asthma in hard-metal workers: bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation tests. Thorax (1983) 1.28
Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens. Thorax (1983) 1.28
Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol (1985) 1.28
Rate and extent of compensatory changes in energy intake and expenditure in response to altered exercise and diet composition in humans. Am J Physiol Regul Integr Comp Physiol (2004) 1.20
The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis (1987) 1.20
Opposing actions of CSW and RasGAP modulate the strength of Torso RTK signaling in the Drosophila terminal pathway. Mol Cell (1998) 1.19
Fabry disease in unselected patients with TIA or stroke: population-based study. Eur J Neurol (2012) 1.16
The effect of graded levels of exercise on energy intake and balance in free-living women. Int J Obes Relat Metab Disord (2002) 1.13
Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Respir Med (1989) 1.11
In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol (1992) 1.09
Identification of a GTPase-activating protein homolog in Schizosaccharomyces pombe. Mol Cell Biol (1991) 1.08
Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases. Am Rev Respir Dis (1987) 1.08
An abdominal left ventricular assist device: preclinical studies. Ann Thorac Surg (1975) 1.07
Identification of inorganic dust particles in bronchoalveolar lavage macrophages by energy dispersive x-ray microanalysis. Arch Environ Health (1986) 1.07
Complement activation during cardiopulmonary bypass. Anaesthesia (1980) 1.06
The effect of graded levels of exercise on energy intake and balance in free-living men, consuming their normal diet. Eur J Clin Nutr (2002) 1.06
Nuclear-fueled circulatory support systems XII: current status. Trans Am Soc Artif Intern Organs (1974) 1.06
Morphology of intestinal allograft rejection and the inadequacy of mucosal biopsy in its recognition. Br J Exp Pathol (1986) 1.06
Are routine iron stains on bone marrow trephine biopsy specimens necessary? J Clin Pathol (2005) 1.05
Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1981) 1.03
Clinical applications of bronchoalveolar lavage: an interim view. Br J Dis Chest (1986) 1.02
Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med (1994) 1.02
Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis (2007) 1.01
An abdominal left ventricular assist device (ALVAD): chronic hemodynamic analyses in the calf. Trans Am Soc Artif Intern Organs (1974) 1.01
Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy. Am Rev Respir Dis (1991) 1.01
Effects of an abdominal left ventricular assist device on myocardial oxygen supply/demand ratios in normally perfused and ischemic bovine myocardium. Ann Thorac Surg (1975) 1.01
Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. Thorax (1984) 0.99
Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes. Diabetologia (2006) 0.98
HERMES: good reasons for harmonising education and training in respiratory medicine. Eur Respir J (2006) 0.98
Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes. Thorax (1988) 0.98
European curriculum recommendations for training in adult respiratory medicine: crossing boundaries with HERMES. Eur Respir J (2008) 0.97
Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery. Eur J Respir Dis (1986) 0.96
Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet (1999) 0.96
Signal transduction. Histidine kinases hog the limelight. Nature (1994) 0.96
Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child (1998) 0.96
A risk-benefit assessment of prasugrel, clopidogrel, and genotype-guided therapy in patients undergoing percutaneous coronary intervention. Clin Pharmacol Ther (2012) 0.95
Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med (1998) 0.93
Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis. Clin Exp Immunol (1992) 0.93
Complement activation in Henoch-Schönlein purpura. Pediatr Nephrol (1997) 0.92
Chronic pulmonary sarcoidosis: relationship between lung lavage cell counts, chest radiograph, and results of standard lung function tests. Thorax (1985) 0.91
Functional analysis of mature hematopoietic cells from mice lacking the betac chain of the granulocyte-macrophage colony-stimulating factor receptor. Blood (1998) 0.91
Cloning of the CDC7 gene of Saccharomyces cerevisiae in association with centromeric DNA. Gene (1985) 0.91
Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol (2002) 0.91
Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history. Chest (1994) 0.91
Late complications of undetected urethral stricture after cardiac surgery in a child. BMJ (1991) 0.90
Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporos Int (2013) 0.90
Clinical applications of bronchoalveolar lavage. Clin Chest Med (1987) 0.90
Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort study. J Inherit Metab Dis (2014) 0.90
Diagnosing Gaucher disease: an on-going need for increased awareness amongst haematologists. Blood Cells Mol Dis (2012) 0.89
Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis). Clin Exp Immunol (1982) 0.89
Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis. Chest (1989) 0.89
Description and evaluation of a Newton-based electronic appetite rating system for temporal tracking of appetite in human subjects. Physiol Behav (2001) 0.89
Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats. Thorax (1987) 0.89
Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study. J Inherit Metab Dis (2014) 0.88
Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile. Clin Exp Immunol (1988) 0.88
Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group. Arch Dis Child (2000) 0.87
Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease. Blood Cells Mol Dis (2013) 0.86
Cord blood telomere length, telomerase activity and inflammatory markers in pregnancies in women with diabetes or gestational diabetes. Diabet Med (2010) 0.86
Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery. Br J Pharmacol (2009) 0.86
Fabry disease and the skin: data from FOS, the Fabry outcome survey. Br J Dermatol (2007) 0.85
Pulmonary disorders associated with Sjögren's syndrome. Q J Med (1981) 0.85
Clinical guidelines and indications for bronchoalveolar lavage (BAL): occupational lung diseases due to inhalation of inorganic dust. Eur Respir J (1990) 0.85
Control of growth and differentiation by Drosophila RasGAP, a homolog of p120 Ras-GTPase-activating protein. Mol Cell Biol (1999) 0.85
In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expression. Gene Ther (2011) 0.85
Adopting children with attachment problems. Child Welfare (1999) 0.85
Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis. Thorax (1990) 0.85
Increased accuracy of renal allograft rejection diagnosis using combined perforin, granzyme B, and Fas ligand fine-needle aspiration immunocytology. Transplantation (2000) 0.84
Interferon in lungs. Lancet (1989) 0.83
Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of alpha-tocopherol supplementation. Clin Sci (Lond) (2001) 0.83
Cells, enzymes and interstitial lung disease. The Philip Ellman Lecture. J R Coll Physicians Lond (1981) 0.83
The Schizosaccharomyces pombe mra1 gene, which is required for cell growth and mating, can suppress the mating inefficiency caused by a deficit in the Ras1 activity. Genes Cells (1996) 0.83
Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study. J Inherit Metab Dis (2014) 0.82
Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat. Calcif Tissue Int (2008) 0.82
An abdominal left ventricular assist device: experimental physiologic analyses. J Surg Res (1974) 0.81
Bronchoalveolar macrophages in sarcoidosis and cryptogenic fibrosing alveolitis. Clin Allergy (1981) 0.81
Long-term outcomes of liver transplantation in type 1 Gaucher disease. Am J Transplant (2010) 0.81
Immunosuppression by pulmonary surfactant: mechanisms of action. Thorax (1990) 0.81